Fig. 9: ^manSNI-mediated TB sono-immunotherapy.

^manSNI targets TBG to selectively kill M.tb in macrophages, triggers potent innate and adaptive anti-TB immune responses to reverse the immunosuppression of TBG, achieving efficient treatment of TB and prevention of recurrence.